Program FAQs

Discover answers to the most commonly asked questions about biophyle's Clinical Trial Initiative

How do I apply to the biophyle Trial accelerator?

There is an Apply Now button on the Clinical Trial Initiative page of this website! This will take you to Award Force, which is our third-party platform used for receiving and reviewing applications.

What is the Application Process like?

In the online application you’ll complete on Award Force, you’ll be asked to submit answers to several questions, with a character-limitation for each answer. Additionally, you’ll be able to submit any additional documents you’d like for us to see, including research papers, business plans, pitch decks, protocols, videos, etc. Once your application has been submitted, the HealthTech Arkansas and SymBiosis teams will review your application. Applications will be reviewed as they are submitted, and our clinical trial sites will conduct interviews and choose with whom they want to partner.

What kind of companies are you looking for?

We’re looking primarily for late pre-clinical companies (those moving into their Phase I clinical trials within 12 months), as well as early clinical companies seeking to initiate a Phase II trial within 12 months of entering the program.

Can we apply if our company is not based in the US?

Absolutely! We anticipate international companies will target our program to reach U.S. patients, access the U.S. market, and collect data that will be instrumental in achieving U.S. FDA approval.

What disease areas do you target?

Applicants developing therapeutics in any disease area are welcome to apply, though we have a particular emphasis on oncology, immunology and cardiometabolic diseases.

Do you have an academic medical center participating as a site?

Yes, the University of Arkansas for Medical Sciences (“UAMS”) is a committed participant of the program through the Winthrop Rockefeller Cancer Institute and through other areas of clinical research focus. Additionally, the Arkansas Children’s Research Institute is affiliated with UAMS and can host trials with pediatric patients.

Will I have to locate my company to Arkansas to participate in this program?

No! There’s absolutely no requirement for your company to be in Arkansas for a certain period of time during the program, or for your company to establish operations here. During the course of your trials, your representatives will be onsite as needed, just as if you’re conducting a clinical trial anywhere else in the world. However, one goal of the biophyle Trial Accelerator is to help develop the life sciences activities in the State of Arkansas. As such, we plan to introduce you to a number of resources in the state and the Northwest Arkansas region specifically that we believe make a compelling case for doing business here.